Caris Discovery

Let Caris help you unlock truly novel and otherwise inaccessible targets for your discovery pipeline.

Highly differentiated, orthogonal multi-omics method for target discovery

Adaptive dynamic artificial polyligand targeting (ADAPT)

Unbiased target ID platform that uses a broad library of aptamers to profile biological samples at a systems-wide scale

Repository of over 9M+ FFPE slides across oncology

Unparalleled data and robust validation pipeline

WES and WTS: full coverage DNA & RNA molecular information paired to clinical outcomes data

State of the art equipment and facilities: 45 NovaSeqs, 300K+ Sq. Ft., dedicated Caris Discovery wet lab

Differentiation and aggregate strength of the Caris platform unlocks otherwise inaccessible target discovery opportunities

unparalleled data

innovation lab

broad footprint

Note: Data current as of August 1, 2022

unparalleled data


innovation lab


broad footprint


Note: Data current as of August 1, 2022

State of the art equipment and facilities for target ID and drug development

Footprint of 45 NovaSeqs

  • Leading high throughput oncology profiling lab for NovaSeqs in U.S.
  • Improvements in throughput efficiencies
  • Enhanced depth of coverage

4 Precision Medicine Laboratories (Phoenix and Dallas) Totaling 300K+ Sq. Ft.

Card image cap

Clinical Tissue Lab
(Cotton Center,
Phoenix, AZ)

Card image cap

Drug Target Discovery Lab
(Papago,
Phoenix, AZ)

Card image cap

Clinical Blood Lab
(Cotton Center,
Phoenix, AZ)

Card image cap

Coming Soon -
Clinical Tissue & Blood Lab
(Irving, TX)

AI technology enabled platform for target discovery agnostic to treatment modality

Antibody-drug conjugates (ADCs), multi-specifics, radiopharmaceuticals, cell therapies, small molecules, degraders, and others

Caris_Adapt_Biotargeting_CMYK.png
Caris_MI_Exome_CMYK.png
Caris_MI_Transcriptome_CMYK.png
Caris_CODE_CMYK.png

Druggable Genome

10K+ Candidates

Disease Prevalence / Specificity & RWE

1,000 Candidates

Protein Target Validation

100 – 1,000 Candidates


100s of novel target candidates to validate and partner externally

Contact Us

"*" indicates required fields

Name*
Preferred contact method*
Best time to contact
: